A weight loss drug repurposed to save lives

post-image

A weight-loss drug could be repurposed to prevent organ failure in patients in intensive care, research from the University of Auckland and Monash University in Australia shows.

Orlistat, marketed in New Zealand as Xenical, can be retooled to treat conditions such as severe acute pancreatitis, severe infection and haemorrhagic shock, according to the study published in the International Journal of Pharmaceutics.

Patent filed. Seeking commercial partners.

https://doi.org/10.1016/j.ijpharm.2021.120247



What do you think?


You must be logged in to post a comment.
Comments
mobiletestshanil @ 2021.02.18 3:06 AM

Good Idea



Related Posts

Healthcare

post-image

New pain relief though nerve cooling implant
26 July 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

A defibrillator near every home
23 July 2022 by Lynn Wood 0 Comments

Healthcare

post-image

Phage therapy .. a new frontier in healthcare
26 June 2022 by Trevor Rowe 0 Comments